brain injury
US DOD Awards $4.9M to UTHealth Houston to Test Autologous Stem Cell Therapy for Severe Brain Injury
The treatment involves repeated intravenously infused adipose-derived mesenchymal stem cells, which could reduce neuroinflammation.
The treatment involves repeated intravenously infused adipose-derived mesenchymal stem cells, which could reduce neuroinflammation.